The iShares Health Innovation Active ETF (the “Fund”) seeks to maximize total return by investing in innovative and emerging companies in the healthcare sector.
iShares Health Innovation Active ETF · Issued by iShares
| GILD | Gilead Sciences Inc | 5.01% |
| MRK | Merck & Co Inc | 4.99% |
| ABBV | AbbVie Inc | 4.61% |
| JNJ | Johnson & Johnson | 4.27% |
| CRL | Charles River Laboratories International Inc | 4.22% |
| TMO | Thermo Fisher Scientific Inc | 4.12% |
| EW | Edwards Lifesciences Corp | 3.95% |
| MRNA | Moderna Inc | 3.86% |
| IQV | IQVIA Holdings Inc | 3.72% |
| DHR | Danaher Corp | 3.64% |
No recent news for BMED. The ingest cron pulls every 15 minutes during market hours.